Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 400-830-7 | CAS number: 104810-48-2 EVERSORB 80; TINUVIN 1130; TINUVIN 213
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.35 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 10
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 3.5 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- Esters are not susceptible to acid catalysed hydrolysis in the stomach, but to esterase activity in the plasma. The target organ is the liver.
- AF for dose response relationship:
- 1
- Justification:
- A NOEL is available.
- AF for differences in duration of exposure:
- 2
- Justification:
- A 90-day study in rats is available.
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- included in modification of the dose descriptor starting point
- AF for other interspecies differences:
- 1
- Justification:
- Liver identified as target organ in rabbits and rats. Value in rats due to peroxisome proliferation used to derive NOEL.
- AF for intraspecies differences:
- 5
- Justification:
- worker
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
- Justification:
- Various mechanistic studies available.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- A factor of 0.1 is included to account for the high molecular weight and the high log Pow of the components.
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- Justification:
- subchronic study
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 1
- Justification:
- Liver identified as target organ in rabbits and rats. Value in rats due to peroxisome proliferation used to derive NOEL.
- AF for intraspecies differences:
- 5
- Justification:
- worker
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
A 28 d and a 90 d repeated dose oral toxicity study as well as studies on toxicity to reproduction with rats and rabbits with the test substance are available. The liver was identified as the target organ. A NOAEL of 2 mg/kg bw was identified as the NOAEL for subchronic exposure. The substance is a potent peroxisome proliferator in rats. It is not genotoxic.
For effects observed in the reproductive toxicity studies, the same or higher NOELs were established. The relevant period was covered, so no correction factor for study duration is needed for these endpoints. The DNEL derived from the repeated dose toxicity is lowest and gives adequate safety for the other endpoints.
In order to adjust for inhalation, modifications have to be made for workers. Factors were applied to adjust for human respiratory conditions as well as duration of exposure. An assessment factor of 1 was used for differences in absorption between oral and inhalative route. Further conversion factors were used as advised in the ECHA-guidance Chapter R. 8: Conversion of oral dose to corresponding air concentration: 1/0.38; Correction for respiratory volume under light activity: 6.7/10.
Corrected starting point (worker): 2 mg/kg bw/day x 1/0.38 m3/kg bw/d x 6.7 m3 (8h)/10 m3 (8h) = 3.5 mg/m3
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.085 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 20
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1.7 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- see worker
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- included in modification of the dose descriptor starting point
- AF for other interspecies differences:
- 10
- AF for intraspecies differences:
- 1
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown (no further information necessary)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.25 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 20 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- see worker
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 1
- AF for intraspecies differences:
- 10
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 0.025 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 80
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 2 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- not needed.
- AF for dose response relationship:
- 1
- AF for differences in duration of exposure:
- 2
- AF for interspecies differences (allometric scaling):
- 4
- AF for other interspecies differences:
- 1
- AF for intraspecies differences:
- 10
- AF for the quality of the whole database:
- 1
- AF for remaining uncertainties:
- 1
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
In order to adjust for inhalation, modifications have to be made for the general population. Factors were applied to adjust for human respiratory conditions as well as duration of exposure. An assessment factor of 1 was used for differences in absorption between oral and inhalative route. Further conversion factors were used as advised in the ECHA-guidance Chapter R. 8: Conversion of oral dose to corresponding air concentration: 1/0.38; Correction for respiratory volume under light activity: 6.7/10.
Corrected starting point (general population): 2 mg/kg bow/day x 1/1.15 m3/kg bw/d = 1.7 mg/m3
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
